Article
Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila.
PloS one - 27 Feb 2008
Iijima Koichi, Chiang Hsueh-Cheng, Hearn Stephen A, Hakker Inessa, Gatt Anthony, Shenton Christopher, Granger Linda, Leung Amy, Iijima-Ando Kanae, Zhong Yi
Abstract excerpt
Aggregation of the amyloid-beta-42 (Abeta42) peptide in the brain parenchyma is a pathological hallmark of Alzheimer's disease (AD), and the prevention of Abeta aggregation has been proposed as a therapeutic intervention in AD. However, recent reports indicate that Abeta can form several different prefibrillar and fibrillar aggregates and that each aggregate may confer different pathogenic effects, suggesting...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
